Vita Life Sciences Limited · ASX:VLS
Vita Life Sciences — Shareholder Meeting (May 2008)
21 slides from Vita Life Sciences's shareholder meeting presentation, May 23, 2008
Slide 1: Summary of Managing Director’s Address
Vita Life Sciences Limited (“Vita Life”) Annual General Meeting 23 May 2008 Summary of Managing Director’s Address Opening: Mr Eddie Tie highlighted the milestones in 2007 being: • Company’s listing on the ASX; • Positive shareholders’ funds; • Reduction in borrowings; • Expansion into new markets (
Slide 2: Forecast for 6 months ended 30 June 2008
Forecast for 6 months ended 30 June 2008: Sales are forecast to be approximately 20% higher than previous corresponding period. Established business units in Australia, Singapore and Malaysia are forecast to be profitable. However, the costs of establishing new business units in Thailand, China and
Slide 3: Shareholder Presentation Annual General Meeting
Shareholder Presentation Annual General Meeting 23 May 2008 0
Slide 4: Chairman’s Welcome
Chairman’s Welcome Welcome to the Annual General Meeting of Vita Life Sciences Limited 1
Slide 5: Agenda
Agenda 1. Welcome 2. Managing Directors’ Review 3. Ordinary and Special Business: Resolutions 1 - 8 4. Question Time 5. Close 2
Slide 6: Highlights
Highlights • Listed on ASX • Positive shareholders’ funds • Substantial reduction in borrowings • Platform established for growth • Established investment division • Completed divestment of former medical division 3
Slide 7: Financial Highlights
Financial Highlights • Positive sales growth & improved gross profit • Comparison of profit/ loss not relevant – 2006 results include profit from divestment 4
Slide 8: Normalised Operating Performance
Normalised Operating Performance • Loss as a result of costs in establishing new business units 5
Slide 9: Sales by Geographical segment
Sales by Geographical segment Singapore $2.80 m Others $0.08 m Malaysia $3.90 m Australia $5.06 m 6
Slide 10: Financial Position
Financial Position • Positive shareholders’ funds • Substantial reduction in borrowings 7
Slide 11: Summary of cash flow
Summary of cash flow • Continued positive operating cash flow • Substantial repayment of borrowings 8
Slide 12: Health Division’s Product Brands
Health Division’s Product Brands 9
Slide 13: Health Division 2007: Brand equity enhancement
Health Division 2007: Brand equity enhancement • Continue to grow market position in 3 established markets • Launched VitaLife, the Multi-Level-Marketing unit • Launched Pharma Direct, affordable supplements brand • Launched VitaHealth into Thailand • Obtained approvals to expand Herbs of Gold into
Slide 14: Health Division 2007: Brand equity enhancement (contd.)
Health Division 2007: Brand equity enhancement (contd.) • Expanded our marketing channels: Over-the-counter (OTC): Pharmacy and health food channels; Multi-Level-Marketing (MLM): Direct marketing to consumers; Pharma Direct: Affordable Supplements Direct to Practitioners 11
Slide 15: Investment Division
Investment Division • First investment: New property development project 372 units of houses and shops project in Malaysia Estimated gross development value: $30.0 mil Launched Phase 1 in August 2007 Group has 20.1% share of profit 12
Slide 16: Jan – June 2008
Jan – June 2008 • Sales up 20% 1st half 08 • Established business units profitable • Low gearing $0.75 m to $1.00 m debt • EBIT for half year June 08 loss of $0.50m: Established business profitable offset by costs of establishing new business units Compliance costs of a listed company for 1st time 1
Slide 17: Outlook for 2008
Outlook for 2008 • Group to make small profit in FY2008 • Continue to develop new business units • China business to contribute • Sustainable competitive advantages • Remain confident of our strategy: Expanding existing & building new businesses 14
Slide 18: Agenda
Agenda 1. Welcome 2. Managing Directors’ Review 3. Ordinary and Special Business: Resolutions 1 - 8 4. Question Time 5. Close 15
Slide 19: Proxy Summary
Proxy Summary con oO oO ff Adoption of Remuneration Report 25,331,380 Election of Director 24 889 699 Non-marketable parcels & Small Holding Sale facility 25,361,429 Underwriting fee to CVCV 17,495 552 Share issue to VBH 25,363,698 Issue of Options to BW 19,284,701 Dividend Reinvestment Plan 25,367
Slide 20: Summary
Summary • Share purchase plan with aim to raise $2 million in new capital to fund continued expansion of new business units • New business units’ initiatives will lead to stronger & profitable group 17
Slide 21: Thank You
Thank You